BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 16.64 Delayed Data As of 3:59pm ET |  -0.07 / -0.42%Today’s Change | 3.30 Today|||52-Week Range 17.74 | +123.36% Year-to-Date |
Latest BCRX News | Press Releases
No recent news for BioCryst Pharmaceuticals Inc.
Today’s Trading
| Previous close | 16.71 |
| Today’s open | 16.66 |
| Day’s range | 16.26 - 16.86 |
| Volume | 122,899 |
| Average volume (3 months) | 5,015,988 |
| Market cap | $2.8B |
Data as of 3:59pm ET, 06/22/2021
Growth & Valuation
| Earnings growth (last year) | -16.03% |
| Earnings growth (this year) | -1.92% |
| Earnings growth (next 5 years) | +19.86% |
| Revenue growth (last year) | -63.53% |
| P/E ratio | NM |
| Price/Sales | 69.96 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AXSMAxsome Therapeutics ... | +0.42 | +0.59% |
| ---- | ||
| EDITEditas Medicine Inc | -0.43 | -1.17% |
| NGMNGM Biopharmaceutica... | +0.26 | +1.29% |
Data as of 4:00pm ET, 06/22/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $17.8M |
| Annual profit (last year) | -$182.8M |
| Net profit margin | -1,026.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
